Investors watched in horror as shares of the world's largest biopharmaceutical companies tumbled during the first quarter of 2020. However, thanks to some swift action when the novel coronavirus was still just a blip on the radar, Regeneron (NASDAQ: REGN) and Gilead Sciences (NASDAQ: GILD) did more than avoid the COVID-19 carnage -- their stock prices soared.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,